GERACI, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 602
EU - Europa 209
AS - Asia 94
AF - Africa 6
OC - Oceania 6
Totale 917
Nazione #
US - Stati Uniti d'America 602
RU - Federazione Russa 129
SE - Svezia 37
SG - Singapore 33
IE - Irlanda 28
HK - Hong Kong 27
CN - Cina 16
VN - Vietnam 12
AU - Australia 5
CI - Costa d'Avorio 5
IN - India 5
ES - Italia 4
IT - Italia 3
UA - Ucraina 3
DE - Germania 1
FR - Francia 1
GB - Regno Unito 1
GR - Grecia 1
MU - Mauritius 1
NL - Olanda 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 917
Città #
Santa Clara 173
Fairfield 81
Seattle 46
Cambridge 36
Ashburn 31
Houston 30
Wilmington 30
Woodbridge 30
Dublin 28
Singapore 27
Hong Kong 20
Dong Ket 12
Medford 12
Buffalo 10
Lawrence 10
Princeton 10
Beijing 9
Ann Arbor 8
Chandler 7
Abidjan 5
Melbourne 5
Mumbai 5
Norwalk 5
Barcelona 4
San Diego 4
Shanghai 4
Hillsboro 3
Zhuhai 2
Amstelveen 1
Auckland 1
Boardman 1
Cedar Knolls 1
Falls Church 1
Guangzhou 1
Hounslow 1
Laurel 1
Moscow 1
Redmond 1
Thessaloniki 1
Yubileyny 1
Totale 659
Nome #
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: A European perspective 121
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: Insights from the GHOST-EU registry 113
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry 95
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry 93
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 90
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries 89
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 87
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 85
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry 85
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 70
Totale 928
Categoria #
all - tutte 2.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 0 0 0 0 0 22 21 21 8 12 4
2020/202157 4 6 2 6 4 2 2 3 6 4 4 14
2021/202270 1 3 2 2 3 3 5 7 4 3 14 23
2022/2023104 17 20 11 3 0 22 16 5 5 1 3 1
2023/202441 3 7 14 5 5 0 0 4 0 0 2 1
2024/2025404 23 50 38 68 133 92 0 0 0 0 0 0
Totale 928